| Bioactivity | KIF18A-IN-13 (Compound 16) is an effective and orally active inhibitor of KIF18A with anticancer activity in vivo. KIF18A-IN-13 can be utilized for research in ovarian cancer[1]. |
| CAS | 3029503-57-6 |
| Formula | C28H34F2N4O4S |
| Molar Mass | 560.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang C, et al. Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer[J]. ACS Medicinal Chemistry Letters, 2024. |
KIF18A-IN-13
CAS: 3029503-57-6 F: C28H34F2N4O4S W: 560.66
KIF18A-IN-13 (Compound 16) is an effective and orally active inhibitor of KIF18A with anticancer activity in vivo. KIF18
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.